News
bioMérieux, a world leader in the field of in vitro diagnostics, announces that its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat plus (R/STplus) Panel and BIOFIRE® SPOTFIRE® Respiratory/Sore Throat plus (R/STplus) Panel Mini have been CE-marked under the IVDR*. The certification includes conformity assessment for near-patient testing, enabling its use outside traditional laboratories, directly at the point of care.
Swipe to discover more
-
bioMérieux – 2025 Financial Results
Consolidated sales amounted to €4,070 million in 2025, up 6.2% like-for-like from €3,980 million in the prior year period. Reported growth stood at +2.3% for the period. -
Decrease Antibiotic and Steroid Prescribing While Increasing Clinician Confidence: The Strong Case for a Novel Rapid Multiplex PCR in Urgent Care
Combining an antibiotic stewardship program (ASP) with a 15-pathogen viral panel to reduce inappropriate antibiotic prescribing.
-
Faster Answers, Clearer Decisions: How Real Life ED Use of Rapid Multiplex PCR Improves the Patient Experience
Respiratory symptoms send millions of people to emergency departments (EDs) every year. For clinicians, sorting through those symptoms quickly isn’t easy. For patients, that uncertainty can be stressful: long waits, unclear answers, and sometimes unnecessary treatments, including antibiotics that won’t help viral infections.
Enabling Decision-Making
- BIOMÉRIEUX ESHOP
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- BIOMÉRIEUX ESHOP
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19